Extracellular Vesicles and Circulating Nucleic Acids

|

OAE Publishing Inc.
USA
生物学
Frontier Science Journal
英语
金色OA
/
PMC, Scopus, CNKI, CAS

Publishing Information

/
单盲

Founding year

44196

Publishing Frequency

4

Number of articles per year

37

(2023)

Rejection Rate

49%

(2023)

Open Access

CC BY

Content

研究型论文; 综述; 其他(观点、评论、短讯、亮点、会议报告)
不接收
邀请来稿(期刊主要分享细胞外囊泡和循环核酸(包括 DNA、RNA 和 miRNA)及其治疗用途领域的研究数据、新方法、综述和评论。致力于快速发表原创研究成果,以增进我们对细胞外囊泡和循环核酸的分子和细胞生物学、生物发生和起源的了解;以及它们作为疾病状态诊断、预测和监测的生物标志物以及治疗学的用途。特别鼓励具有临床相关性的稿件,以促进从基础科学到临床应用的转化。接受标准是科学卓越性和原创性。所有涉及使用动物和人类受试者的作品都必须经过机构审查委员会的批准,并遵守公认的国际道德标准。)
The journal is committed to the rapid publication of original findings that increase our understanding of the molecular and cell biology, biogenesis, and origin of extracellular vesicles and circulating nucleic acids; and their use as biomarkers for the diagnosis, prognostication and surveillance of disease states, and in therapeutics. Manuscripts with clinical relevance are especially encouraged to promote the translation from basic science to clinical applications. The criteria for acceptance are scientific excellence and originality. All works involving the use of animals and human subjects must have been approved by institutional review committees and adhere to accepted international ethical standards.